Skip to main content

Table 2 Blood test result at the time of consultation of case 2

From: Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature

Laboratory findings

 

Reference value

WBC (×103/μL)WBC (×103/μL)

3

3.3 - 8.6

Seg (%)

81

38 - 74

Lymph (%)

7.9

16.5 - 49.5

Mono (%)

6.3

2 - 10

Eosino (%)

4.7

0 - 8.5

RBC (×106μL)RBC (×106μL)

3.01

4.35 - 5.55

Hg (g/dL)

10.1

13.7 - 16.8

Hct (%)

30.4

40.7 - 50.1

Plt (μL)

243

158 - 348

AST (IU/L)

18

13 - 30

ALT (IU/L)

16

10 - 42

LDH (IU/L)

261

124 - 222

BUN (mg/dL)

13

8 - 20

Cr (mg/dL)

0.64

0.65 - 1.07

CRP (mg/dL)

4.42

0.00 - 0.14

KL-6 (U/mL)

715

105.3 - 401.2

SP-D (ng/mL)

182

< 110

Anti-nuclear antibodies (n times)

< 80

< 80

Anti-ARS antibody (INDEX)

< 5.0

< 25

MPO-ANCA (U/mL)

< 1.0

< 3.5

PR3-ANCA (U/mL)

< 1.0

< 3.5

Beta D-Glucan (pg/mL)

17.1

< 20

Cytomegalovirus antigen C7HRP

negative